Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities (Details)

v3.22.1
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Accrued Expenses and Other Current Liabilities    
Compensation and benefits $ 2,132 $ 2,919
Commercial expenses 107 605
Legal expenses 124 784
Clinical trial expenses 550  
Pharmaceutical development expenses 161 413
Credit balances to customers 87  
Accrued purchases 271  
Other accrued expenses and other current liabilities 415 447
Total accrued expenses and other current liabilities $ 3,847 $ 5,168